Corcept Therapeutics
CORT
#2447
Rank
A$9.26 B
Marketcap
$87.82
Share price
2.03%
Change (1 day)
145.66%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2024 (TTM): A$0.21 Billion

According to Corcept Therapeutics 's latest financial reports the company's current earnings are A$0.62 Billion. In 2023 the company made an earning of A$0.17 Billion a decrease over its 2022 earnings that were of A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.21 B24.83%
2023 A$0.17 B-4.75%
2022 A$0.17 B-9.51%
2021 A$0.19 B-2.91%
2020 A$0.20 B14.87%
2019 A$0.17 B24.71%
2018 A$0.14 B69.32%
2017 A$83.78 M419.26%
2016 A$16.13 M-395.64%
2015 -A$5.46 Million-87.53%
2014 -A$43.79 Million-33.44%
2013 -A$65.78 Million
2011 -A$51.26 Million17.84%
2010 -A$43.5 Million35.5%
2009 -A$32.1 Million2.84%
2008 -A$31.21 Million60.81%
2007 -A$19.41 Million-52.14%
2006 -A$40.56 Million20.91%
2005 -A$33.54 Million31.87%
2004 -A$25.44 Million60.54%
2003 -A$15.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$27.64 B 12,066.66%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$13.29 Billion-5,944.77%๐Ÿ‡บ๐Ÿ‡ธ USA
A$21.62 B 9,414.58%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$20.09 B 8,745.21%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.00 B 4,743.09%๐Ÿ‡บ๐Ÿ‡ธ USA
A$23.73 B 10,344.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$45.79 Million-120.15%๐Ÿ‡บ๐Ÿ‡ธ USA
A$39.68 M-82.54%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.62 B 173.06%๐Ÿ‡บ๐Ÿ‡ธ USA